HK$344.80 pre-market for 9678.HK Unisound AI (HKSE) 17 Feb 2026: model flags 29.20% upside

9678.HK stock trades at HK$344.80 pre-market on 17 Feb 2026, down 0.17% from yesterday. The Hong Kong (HKSE) listing shows volume 91,720.00 and a 50-day average price of HK$364.03. Unisound AI Technology Co Ltd. is unprofitable by headline EPS -7.87, but technicals show oversold conditions that interest AI stock traders. This pre-market note examines fundamentals, trading signals, Meyka AI grade and model forecasts to frame near-term moves and risk.

Market snapshot: 9678.HK stock pre-market data

Unisound AI (9678.HK) opens pre-market at HK$344.80 with a previous close of HK$345.40. Day range is HK$300.00 to HK$353.00, year range HK$198.00 to HK$879.00, and market cap about HKD 24,864,716,179.00.

Fundamentals and earnings for 9678.HK stock

Unisound reports EPS -7.87 and PE -44.52, reflecting current losses and growth reinvestment. The company focuses on large language models and UniBrain platform in smart life and healthcare, listed on HKSE after a 2025 IPO. Sector peers trade at an average PE 35.95, so valuation diverges sharply and highlights execution and profit path risk for AI stocks.

Technicals and trading signals for 9678.HK stock

Momentum reads show RSI 29.38 (oversold) and MACD histogram -2.28, which signals short-term negative bias but possible mean reversion. Average volume is 496,959.00 versus current 91,720.00, and relative volume is 2.63, suggesting outsized interest in recent sessions.

Meyka grade and forecast for 9678.HK stock

Meyka AI rates 9678.HK with a score out of 100: 64.97, Grade B, suggestion HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects monthly HK$431.53, quarterly HK$445.47, and yearly HK$275.23. Quarterly projection implies +29.20% upside from the current HK$344.80, while the yearly projection implies -20.19%. Forecasts are model-based projections and not guarantees.

Valuation, catalysts and risks for 9678.HK stock

Key catalysts include UniBrain commercial contracts, healthcare rollouts, and clearer profit margins. Main risks are sustained negative EPS, competition from larger AI players, and regulatory shifts in China affecting AI deployment. Relative to the sector average PE 35.95, the negative PE shows valuation depends on execution and revenue growth rather than multiples today.

Trading strategy for AI stocks: positioning in 9678.HK stock

For traders, watch support near HK$300.00 and resistance at the 50-day average HK$364.03. A short-term swing target aligns with the quarterly forecast at HK$445.47 and a conservative 12-month target at HK$275.23. Risk-manage positions given EPS and volatility. For longer-term AI exposure, scale in with firm stop-loss levels and track UniBrain contract updates on the company site Unisound and filings on the exchange HKEX company page.

Final Thoughts

Key takeaways for 9678.HK stock on 17 Feb 2026: price action at HK$344.80 shows oversold technicals and elevated interest versus average volume. Fundamentals remain challenging with EPS -7.87 and PE -44.52, leaving valuation dependent on revenue and margin inflection. Meyka AI assigns a 64.97/100 score (Grade B, HOLD) based on sector and growth metrics. Our model gives a near-term quarterly target HK$445.47 (+29.20%) and a conservative 12-month level HK$275.23 (-20.19%). Traders should treat the quarterly figure as an upside scenario and the yearly figure as a downside guardrail. Use tight risk controls and follow UniBrain commercial updates and HKSE filings while we track updates on 9678.HK stock with Meyka AI-powered market analysis

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.